---
title: "Junshi Biosciences' Chair Boosts Shareholding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275463354.md"
description: "Junshi Biosciences' Chair Boosts Shareholding"
datetime: "2026-02-10T13:01:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275463354.md)
  - [en](https://longbridge.com/en/news/275463354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275463354.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275463354.md) | [繁體中文](https://longbridge.com/zh-HK/news/275463354.md)


# Junshi Biosciences' Chair Boosts Shareholding



### Related Stocks

- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/en/quote/516500.CN.md)
- [Tianhong CNI BIOMEDICINE ETF (159859.CN)](https://longbridge.com/en/quote/159859.CN.md)
- [Penghua SSE STAR Biology and Medicine ETF (588250.CN)](https://longbridge.com/en/quote/588250.CN.md)
- [OBiO Tech (688238.CN)](https://longbridge.com/en/quote/688238.CN.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/en/quote/159992.CN.md)
- [JUNSHI BIO (01877.HK)](https://longbridge.com/en/quote/01877.HK.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/en/quote/588130.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/en/quote/512290.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/en/quote/159837.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/en/quote/159849.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [Junshi Biosciences (688180.CN)](https://longbridge.com/en/quote/688180.CN.md)

## Related News & Research

- [Henlius Biotech Doses First Patient in Phase 2/3 Breast Cancer Drug Study; Shares Slip 3%](https://longbridge.com/en/news/277421361.md)
- [Sanofi bets on Sino Biopharm’s transplant drug in $1.5bn licensing deal](https://longbridge.com/en/news/277818646.md)
- [These Analysts Cut Their Forecasts On Veeva Systems Following Q4 Results](https://longbridge.com/en/news/277930677.md)
- [03:03 ETSectra acquires Oxipit, advancing autonomous AI capabilities in diagnostic imaging](https://longbridge.com/en/news/277900089.md)
- [Antengene Signs Global License Deal With UCB for Autoimmune Drug Candidate](https://longbridge.com/en/news/277705757.md)